Monument Capital Management Edwards Lifesciences Corp Transaction History

Monument Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $163,312 - $242,173	-1,888 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $192,500 - $242,305	1,888 New	1,888 $222,000
Q3 2020 Oct 23, 2020	SELL	$67.19 - $87.44 $2.15 Million - $2.8 Million	-32,046 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $1.19 Million - $1.6 Million	20,729 Added 183.17%	32,046 $2.22 Million
Q1 2020 Apr 14, 2020	SELL	$52.41 - $81.0 $11,687 - $18,063	-223 Reduced 1.93%	11,317 $2.14 Million
Q4 2019 Jan 14, 2020	SELL	$71.7 - $82.09 $51,050 - $58,448	-712 Reduced 5.81%	11,540 $2.69 Million
Q3 2019 Oct 21, 2019	SELL	$61.55 - $75.43 $42,900 - $52,574	-697 Reduced 5.38%	12,252 $2.69 Million
Q2 2019 Jul 23, 2019	SELL	$55.74 - $64.41 $55,071 - $63,637	-988 Reduced 7.09%	12,949 $2.4 Million
Q1 2019 Apr 10, 2019	SELL	$47.89 - $64.05 $29,739 - $39,775	-621 Reduced 4.27%	13,937 $2.67 Million
Q4 2018 Jan 15, 2019	BUY	$46.41 - $56.94 $675,636 - $828,932	14,558 New	14,558 $2.23 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

Stay updated on Monument Capital Management with notifications on news.